|
ErgamisolDrug - Ergamisol The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Levamisole Hydrochloride
Strength -
EQ 50MG BASE
Applicant -
JANSSEN PHARMA
New Drug Application (NDA) Number -
020035
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jun 18, 1990
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Janssen Pharmaceutica Products Lp
Ergamisol
Eligard 45mg/vial Injectable; Subcutaneous
Eligard 7.5mg/vial Injectable; Subcutaneous Xopenex Eq 0.0103% Base Solution; Inhalation Xopenex Eq 0.021% Base Solution; Inhalation Xopenex Eq 0.042% Base Solution; Inhalation Xopenex Eq 0.25% Base Solution; Inhalation Xopenex Hfa Eq 0.045mg Base/inh Aerosol, Metered; Inhalation Lorfan 1mg/ml Injectable; Injection Ergamisol Eq 50mg Base Tablet; Oral Eligard 30mg/vial Injectable; Subcutaneous NewDrugInformation |